SCHEMBL3224786

SCHEMBL3224786

NC(=O)n1n[c]nc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2855029 0.72 PDPK1 (0.43)
SCHEMBL9107638 0.71 NR1H2 (0.38)
SCHEMBL24500533 0.55 PDPK1 (0.35)
SCHEMBL28565 0.48
Urea SCHEMBL51851 0.47 CYP1A2 (0.50)
Urea SCHEMBL10914180 0.47 CYP1A2 (0.50)
Urea SCHEMBL15483993 0.47 CYP1A2 (0.50)
Carbamic Acid SCHEMBL21315591 0.46 CYP1A2 (0.55)
Urea SCHEMBL3812569 0.45
SCHEMBL27636065 0.45

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7812041-B2 Heterocyclic NF-κB inhibitors 4SC AG (DE) 2010-10-12 US disclosed
US-20100048583-A1 Novel Heterocyclic NF-kB Inhibitors 4SC AG (DE) 2010-02-25 US disclosed
US-20080261971-A1 Novel Heterocyclic Nf-Kb Inhibitors 4SC AG (DE) 2008-10-23 US disclosed
US-20060069102-A1 Novel heterocyclic NF-kB inhibitors 4 SC AG (DE) 2006-03-30 US disclosed